about
Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1.Inhibition of Protein-Protein Interactions: New Options for Developing Drugs against Neglected Tropical Diseases.Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells.Selective degradation of polo-like kinase 1 by a hydrophobically tagged inhibitor of the polo-box domainiSPAAC: Isomer-Free Generation of a Bcl-xL -Inhibitor in Living CellsStafia-1: a STAT5a-Selective Inhibitor Developed via Docking-Based Screening of in Silico O-Phosphorylated FragmentsThe STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5aATP Inhibits the Transcription Factor STAT5b
P50
Q35867866-7D519BD0-5985-452A-A7F8-A48A66AE7713Q38904985-8CFF03B2-7DDE-4E3F-BBAE-D65BAB92BF6EQ47122836-B296C801-D55B-42AE-ADC6-A0CF71246DCCQ57795495-03E6EED2-5C9A-4AB7-9B13-89D62E674A5AQ89149690-E038CF4A-8B54-4030-9EBE-4FE274C6CE7FQ90019171-68B2273D-5C7C-4915-850B-D4BCF5282D6AQ92138625-3B8F6809-BBD1-4410-8E47-9052435AD41CQ93097286-B96FE321-3D5C-42D7-8DA9-66754F78C2E5
P50
description
researcher
@en
wetenschapper
@nl
name
Thorsten Berg
@en
Thorsten Berg
@nl
type
label
Thorsten Berg
@en
Thorsten Berg
@nl
prefLabel
Thorsten Berg
@en
Thorsten Berg
@nl
P31
P496
0000-0003-3109-7696